Imricor Medical Systems has started commercial distribution of its NorthStar mapping system in the US.
According to the company, the technology is the first cardiac mapping and guidance system to utilise magnetic resonance imaging (MRI) during minimally invasive heart procedures, replacing the conventional dependence on X-ray fluoroscopy.
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
The development enables clinicians to visualise the structure and tissue properties of the heart in real time while carrying out interventions and does not require the use of ionising radiation.
Traditional cardiac interventions have relied on X-ray imaging, with limitations in soft-tissue visualisation and exposure risks for patients and staff.
In response, the introduction of sensor-based tools provided partial mapping solutions, but continued to involve exposure to X-rays.
NorthStar is designed to leverage MRI throughout procedures, displaying both the heart and interventional devices within it, and allowing for real-time image manipulation.
Imricor global sales vice-president Greg Englehardt said: “Launching NorthStar in the US marks a pivotal moment for Imricor as we enter the world’s most advanced and influential healthcare market. We are bringing a truly differentiated solution to physicians.
“NorthStar unlocks the full potential of interventional MR, which we call ‘iMR,’ with real-time soft-tissue visualisation, real-time image manipulation, and zero radiation.
“Our US commercial team is already generating demand and building a high-quality pipeline, and we are focused on rapidly converting that momentum into early adoption across key centres.”
Imricor CEO Steve Wedan said: “Imricor has pioneered the field of interventional MR, and we remain at the forefront of delivering a fully-realised ecosystem for cardiac interventional MR procedures.
Imricor plans to present the NorthStar mapping system at the Heart Rhythm Society’s Annual Scientific Sessions in Chicago, Illinois.
